Aminoglycoside Antibiotics Market - Global Outlook and Forecast 2022-2028

January 2022 | 74 pages | ID: AFBDFABE8520EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Aminoglycoside Antibiotics in global, including the following market information:

Global Aminoglycoside Antibiotics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Aminoglycoside Antibiotics Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Aminoglycoside Antibiotics companies in 2021 (%)

The global Aminoglycoside Antibiotics market was valued at 1081.9 million in 2021 and is projected to reach US$ 1345 million by 2028, at a CAGR of 3.2% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Neomycin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Aminoglycoside Antibiotics include Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Aminoglycoside Antibiotics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Aminoglycoside Antibiotics Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Aminoglycoside Antibiotics Market Segment Percentages, by Type, 2021 (%)

• Neomycin
• Tobramycin
• Gentamicin
• Amikacin
• Paromomycin
• Kanamycin

Global Aminoglycoside Antibiotics Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Aminoglycoside Antibiotics Market Segment Percentages, by Application, 2021 (%)

• Veterinary
• Respiratory
• UTI & Pelvic Disease
• Neonatal Sepsis

Global Aminoglycoside Antibiotics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Aminoglycoside Antibiotics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Aminoglycoside Antibiotics revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Aminoglycoside Antibiotics revenues share in global market, 2021 (%)

Key companies Aminoglycoside Antibiotics sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Aminoglycoside Antibiotics sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Britannica
• Novartis Pharmaceuticals
• Merck
• Kremoint Pharma
• Medson Pharmaceuticals
• Allergan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Aminoglycoside Antibiotics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Aminoglycoside Antibiotics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AMINOGLYCOSIDE ANTIBIOTICS OVERALL MARKET SIZE

2.1 Global Aminoglycoside Antibiotics Market Size: 2021 VS 2028
2.2 Global Aminoglycoside Antibiotics Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Aminoglycoside Antibiotics Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Aminoglycoside Antibiotics Players in Global Market
3.2 Top Global Aminoglycoside Antibiotics Companies Ranked by Revenue
3.3 Global Aminoglycoside Antibiotics Revenue by Companies
3.4 Global Aminoglycoside Antibiotics Sales by Companies
3.5 Global Aminoglycoside Antibiotics Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Aminoglycoside Antibiotics Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Aminoglycoside Antibiotics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Aminoglycoside Antibiotics Players in Global Market
  3.8.1 List of Global Tier 1 Aminoglycoside Antibiotics Companies
  3.8.2 List of Global Tier 2 and Tier 3 Aminoglycoside Antibiotics Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Aminoglycoside Antibiotics Market Size Markets, 2021 & 2028
  4.1.2 Neomycin
  4.1.3 Tobramycin
  4.1.4 Gentamicin
  4.1.5 Amikacin
  4.1.6 Paromomycin
  4.1.7 Kanamycin
4.2 By Type - Global Aminoglycoside Antibiotics Revenue & Forecasts
  4.2.1 By Type - Global Aminoglycoside Antibiotics Revenue, 2017-2022
  4.2.2 By Type - Global Aminoglycoside Antibiotics Revenue, 2023-2028
  4.2.3 By Type - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
4.3 By Type - Global Aminoglycoside Antibiotics Sales & Forecasts
  4.3.1 By Type - Global Aminoglycoside Antibiotics Sales, 2017-2022
  4.3.2 By Type - Global Aminoglycoside Antibiotics Sales, 2023-2028
  4.3.3 By Type - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
4.4 By Type - Global Aminoglycoside Antibiotics Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Aminoglycoside Antibiotics Market Size, 2021 & 2028
  5.1.2 Veterinary
  5.1.3 Respiratory
  5.1.4 UTI & Pelvic Disease
  5.1.5 Neonatal Sepsis
5.2 By Application - Global Aminoglycoside Antibiotics Revenue & Forecasts
  5.2.1 By Application - Global Aminoglycoside Antibiotics Revenue, 2017-2022
  5.2.2 By Application - Global Aminoglycoside Antibiotics Revenue, 2023-2028
  5.2.3 By Application - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
5.3 By Application - Global Aminoglycoside Antibiotics Sales & Forecasts
  5.3.1 By Application - Global Aminoglycoside Antibiotics Sales, 2017-2022
  5.3.2 By Application - Global Aminoglycoside Antibiotics Sales, 2023-2028
  5.3.3 By Application - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
5.4 By Application - Global Aminoglycoside Antibiotics Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Aminoglycoside Antibiotics Market Size, 2021 & 2028
6.2 By Region - Global Aminoglycoside Antibiotics Revenue & Forecasts
  6.2.1 By Region - Global Aminoglycoside Antibiotics Revenue, 2017-2022
  6.2.2 By Region - Global Aminoglycoside Antibiotics Revenue, 2023-2028
  6.2.3 By Region - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
6.3 By Region - Global Aminoglycoside Antibiotics Sales & Forecasts
  6.3.1 By Region - Global Aminoglycoside Antibiotics Sales, 2017-2022
  6.3.2 By Region - Global Aminoglycoside Antibiotics Sales, 2023-2028
  6.3.3 By Region - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Aminoglycoside Antibiotics Revenue, 2017-2028
  6.4.2 By Country - North America Aminoglycoside Antibiotics Sales, 2017-2028
  6.4.3 US Aminoglycoside Antibiotics Market Size, 2017-2028
  6.4.4 Canada Aminoglycoside Antibiotics Market Size, 2017-2028
  6.4.5 Mexico Aminoglycoside Antibiotics Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Aminoglycoside Antibiotics Revenue, 2017-2028
  6.5.2 By Country - Europe Aminoglycoside Antibiotics Sales, 2017-2028
  6.5.3 Germany Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.4 France Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.5 U.K. Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.6 Italy Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.7 Russia Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.8 Nordic Countries Aminoglycoside Antibiotics Market Size, 2017-2028
  6.5.9 Benelux Aminoglycoside Antibiotics Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Aminoglycoside Antibiotics Revenue, 2017-2028
  6.6.2 By Region - Asia Aminoglycoside Antibiotics Sales, 2017-2028
  6.6.3 China Aminoglycoside Antibiotics Market Size, 2017-2028
  6.6.4 Japan Aminoglycoside Antibiotics Market Size, 2017-2028
  6.6.5 South Korea Aminoglycoside Antibiotics Market Size, 2017-2028
  6.6.6 Southeast Asia Aminoglycoside Antibiotics Market Size, 2017-2028
  6.6.7 India Aminoglycoside Antibiotics Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Aminoglycoside Antibiotics Revenue, 2017-2028
  6.7.2 By Country - South America Aminoglycoside Antibiotics Sales, 2017-2028
  6.7.3 Brazil Aminoglycoside Antibiotics Market Size, 2017-2028
  6.7.4 Argentina Aminoglycoside Antibiotics Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Aminoglycoside Antibiotics Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Aminoglycoside Antibiotics Sales, 2017-2028
  6.8.3 Turkey Aminoglycoside Antibiotics Market Size, 2017-2028
  6.8.4 Israel Aminoglycoside Antibiotics Market Size, 2017-2028
  6.8.5 Saudi Arabia Aminoglycoside Antibiotics Market Size, 2017-2028
  6.8.6 UAE Aminoglycoside Antibiotics Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Britannica
  7.1.1 Britannica Corporate Summary
  7.1.2 Britannica Business Overview
  7.1.3 Britannica Aminoglycoside Antibiotics Major Product Offerings
  7.1.4 Britannica Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.1.5 Britannica Key News
7.2 Novartis Pharmaceuticals
  7.2.1 Novartis Pharmaceuticals Corporate Summary
  7.2.2 Novartis Pharmaceuticals Business Overview
  7.2.3 Novartis Pharmaceuticals Aminoglycoside Antibiotics Major Product Offerings
  7.2.4 Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.2.5 Novartis Pharmaceuticals Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Aminoglycoside Antibiotics Major Product Offerings
  7.3.4 Merck Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.3.5 Merck Key News
7.4 Kremoint Pharma
  7.4.1 Kremoint Pharma Corporate Summary
  7.4.2 Kremoint Pharma Business Overview
  7.4.3 Kremoint Pharma Aminoglycoside Antibiotics Major Product Offerings
  7.4.4 Kremoint Pharma Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.4.5 Kremoint Pharma Key News
7.5 Medson Pharmaceuticals
  7.5.1 Medson Pharmaceuticals Corporate Summary
  7.5.2 Medson Pharmaceuticals Business Overview
  7.5.3 Medson Pharmaceuticals Aminoglycoside Antibiotics Major Product Offerings
  7.5.4 Medson Pharmaceuticals Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.5.5 Medson Pharmaceuticals Key News
7.6 Allergan
  7.6.1 Allergan Corporate Summary
  7.6.2 Allergan Business Overview
  7.6.3 Allergan Aminoglycoside Antibiotics Major Product Offerings
  7.6.4 Allergan Aminoglycoside Antibiotics Sales and Revenue in Global (2017-2022)
  7.6.5 Allergan Key News

8 GLOBAL AMINOGLYCOSIDE ANTIBIOTICS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Aminoglycoside Antibiotics Production Capacity, 2017-2028
8.2 Aminoglycoside Antibiotics Production Capacity of Key Manufacturers in Global Market
8.3 Global Aminoglycoside Antibiotics Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 AMINOGLYCOSIDE ANTIBIOTICS SUPPLY CHAIN ANALYSIS

10.1 Aminoglycoside Antibiotics Industry Value Chain
10.2 Aminoglycoside Antibiotics Upstream Market
10.3 Aminoglycoside Antibiotics Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Aminoglycoside Antibiotics Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Aminoglycoside Antibiotics in Global Market
Table 2. Top Aminoglycoside Antibiotics Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Aminoglycoside Antibiotics Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Aminoglycoside Antibiotics Revenue Share by Companies, 2017-2022
Table 5. Global Aminoglycoside Antibiotics Sales by Companies, (K Units), 2017-2022
Table 6. Global Aminoglycoside Antibiotics Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Aminoglycoside Antibiotics Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Aminoglycoside Antibiotics Product Type
Table 9. List of Global Tier 1 Aminoglycoside Antibiotics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Aminoglycoside Antibiotics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Aminoglycoside Antibiotics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Aminoglycoside Antibiotics Sales (K Units), 2017-2022
Table 15. By Type - Global Aminoglycoside Antibiotics Sales (K Units), 2023-2028
Table 16. By Application – Global Aminoglycoside Antibiotics Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Aminoglycoside Antibiotics Sales (K Units), 2017-2022
Table 20. By Application - Global Aminoglycoside Antibiotics Sales (K Units), 2023-2028
Table 21. By Region – Global Aminoglycoside Antibiotics Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Aminoglycoside Antibiotics Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Aminoglycoside Antibiotics Sales (K Units), 2017-2022
Table 25. By Region - Global Aminoglycoside Antibiotics Sales (K Units), 2023-2028
Table 26. By Country - North America Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Aminoglycoside Antibiotics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Aminoglycoside Antibiotics Sales, (K Units), 2017-2022
Table 29. By Country - North America Aminoglycoside Antibiotics Sales, (K Units), 2023-2028
Table 30. By Country - Europe Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Aminoglycoside Antibiotics Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Aminoglycoside Antibiotics Sales, (K Units), 2017-2022
Table 33. By Country - Europe Aminoglycoside Antibiotics Sales, (K Units), 2023-2028
Table 34. By Region - Asia Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Aminoglycoside Antibiotics Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Aminoglycoside Antibiotics Sales, (K Units), 2017-2022
Table 37. By Region - Asia Aminoglycoside Antibiotics Sales, (K Units), 2023-2028
Table 38. By Country - South America Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Aminoglycoside Antibiotics Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Aminoglycoside Antibiotics Sales, (K Units), 2017-2022
Table 41. By Country - South America Aminoglycoside Antibiotics Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Aminoglycoside Antibiotics Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Aminoglycoside Antibiotics Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Aminoglycoside Antibiotics Sales, (K Units), 2023-2028
Table 46. Britannica Corporate Summary
Table 47. Britannica Aminoglycoside Antibiotics Product Offerings
Table 48. Britannica Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novartis Pharmaceuticals Corporate Summary
Table 50. Novartis Pharmaceuticals Aminoglycoside Antibiotics Product Offerings
Table 51. Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Merck Corporate Summary
Table 53. Merck Aminoglycoside Antibiotics Product Offerings
Table 54. Merck Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Kremoint Pharma Corporate Summary
Table 56. Kremoint Pharma Aminoglycoside Antibiotics Product Offerings
Table 57. Kremoint Pharma Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Medson Pharmaceuticals Corporate Summary
Table 59. Medson Pharmaceuticals Aminoglycoside Antibiotics Product Offerings
Table 60. Medson Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Allergan Corporate Summary
Table 62. Allergan Aminoglycoside Antibiotics Product Offerings
Table 63. Allergan Aminoglycoside Antibiotics Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Aminoglycoside Antibiotics Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Aminoglycoside Antibiotics Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Aminoglycoside Antibiotics Production by Region, 2017-2022 (K Units)
Table 67. Global Aminoglycoside Antibiotics Production by Region, 2023-2028 (K Units)
Table 68. Aminoglycoside Antibiotics Market Opportunities & Trends in Global Market
Table 69. Aminoglycoside Antibiotics Market Drivers in Global Market
Table 70. Aminoglycoside Antibiotics Market Restraints in Global Market
Table 71. Aminoglycoside Antibiotics Raw Materials
Table 72. Aminoglycoside Antibiotics Raw Materials Suppliers in Global Market
Table 73. Typical Aminoglycoside Antibiotics Downstream
Table 74. Aminoglycoside Antibiotics Downstream Clients in Global Market
Table 75. Aminoglycoside Antibiotics Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Aminoglycoside Antibiotics Segment by Type
Figure 2. Aminoglycoside Antibiotics Segment by Application
Figure 3. Global Aminoglycoside Antibiotics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Aminoglycoside Antibiotics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Aminoglycoside Antibiotics Revenue, 2017-2028 (US$, Mn)
Figure 7. Aminoglycoside Antibiotics Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Aminoglycoside Antibiotics Revenue in 2021
Figure 9. By Type - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 10. By Type - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 11. By Type - Global Aminoglycoside Antibiotics Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 13. By Application - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 14. By Application - Global Aminoglycoside Antibiotics Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 16. By Region - Global Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 17. By Country - North America Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 18. By Country - North America Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 19. US Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 24. Germany Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 25. France Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 33. China Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 37. India Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 39. By Country - South America Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 40. Brazil Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Aminoglycoside Antibiotics Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Aminoglycoside Antibiotics Sales Market Share, 2017-2028
Figure 44. Turkey Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Aminoglycoside Antibiotics Revenue, (US$, Mn), 2017-2028
Figure 48. Global Aminoglycoside Antibiotics Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Aminoglycoside Antibiotics by Region, 2020 VS 2027
Figure 50. Aminoglycoside Antibiotics Industry Value Chain
Figure 51. Marketing Channels